Developments in Cancer Chemotherapy Volume II

Tekijä Workman, Paul
Julkaistu 1990

Probing the Probes: Fitness Factors For Small Molecule Tools

Tekijä Workman, Paul, Collins, Ian
Julkaistu 2010

Hsp90 molecular chaperone inhibitors: Are we there yet?

Tekijä Neckers, Len, Workman, Paul
Julkaistu 2012

Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

Tekijä Blagg, Julian, Workman, Paul
Julkaisussa Cancer Cell (2017)

Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

Tekijä Blagg, Julian, Workman, Paul
Julkaisussa Cancer Cell (2017)

A stressful life (or death): Combinatorial proteotoxic approaches to cancer-selective therapeutic vulnerability

Tekijä Workman, Paul, Davies, Faith E.
Julkaistu 2011

Discovering and developing PI3 kinase inhibitors for cancer: Rapid progress through academic-biotech-pharma interactions

Tekijä Raynaud, Florence I, Workman, Paul
Julkaistu 2011

Increase of oleic acid in erythrocytes associated with malignancies

Tekijä Metcalfe, Su, Newman, Hugh, Workman, Paul
Julkaistu 1985

The expanding proteome of the molecular chaperone HSP90

Tekijä Samant, Rahul S, Clarke, Paul A, Workman, Paul
Julkaistu 2012

Discovery of small molecule cancer drugs: Successes, challenges and opportunities

Tekijä Hoelder, Swen, Clarke, Paul A., Workman, Paul
Julkaistu 2012

Shock about heat shock in cancer

Tekijä de Billy, Emmanuel, Travers, Jon, Workman, Paul
Julkaistu 2012

E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells

Tekijä Samant, Rahul S., Clarke, Paul A., Workman, Paul
Julkaistu 2014

Structure-based drug design: aiming for a perfect fit

Tekijä van Montfort, Rob L.M., Workman, Paul
Julkaisussa Essays Biochem (2017)

Finding the needle in the haystack: why high-throughput screening is good for your health

Tekijä Aherne, G Wynne, McDonald, Edward, Workman, Paul
Julkaistu 2002

Inhibiting the molecular evolution of cancer through HSP90

Tekijä Martins, Ana Sofia, Davies, Faith E, Workman, Paul
Julkaistu 2012

Blocking the survival of the nastiest by HSP90 inhibition

Tekijä Workman, Paul, Clarke, Paul A., Al-Lazikani, Bissan
Julkaisussa Oncotarget (2016)

Distinctive Behaviors of Druggable Proteins in Cellular Networks

Tekijä Mitsopoulos, Costas, Schierz, Amanda C., Workman, Paul, Al-Lazikani, Bissan
Julkaisussa PLoS Comput Biol (2015)

Drugging PI3K in cancer: refining targets and therapeutic strategies

Tekijä Yap, Timothy A, Bjerke, Lynn, Clarke, Paul A, Workman, Paul
Julkaisussa Curr Opin Pharmacol (2015)

Polypharmacology in Precision Oncology: Current Applications and Future 
Prospects

Tekijä Antolin, Albert A., Workman, Paul, Mestres, Jordi, Al-Lazikani, Bissan
Julkaisussa Curr Pharm Des (2016)

SiGNet: A signaling network data simulator to enable signaling network inference

Tekijä Coker, Elizabeth A., Mitsopoulos, Costas, Workman, Paul, Al-Lazikani, Bissan
Julkaisussa PLoS One (2017)